PMID- 10462479 OWN - NLM STAT- MEDLINE DCOM- 19991001 LR - 20141120 IS - 0006-291X (Print) IS - 0006-291X (Linking) VI - 262 IP - 2 DP - 1999 Aug 27 TI - Nitric oxide inhibits ornithine decarboxylase by S-nitrosylation. PG - 355-8 AB - Ornithine decarboxylase (ODC) is the initial enzyme in the polyamine synthetic pathway, and polyamines are required for cell proliferation. We have shown previously that nitric oxide (NO) inhibits ODC activity in Caco-2 cells and in crude cell lysate preparations. In this study we examined the mechanism by which NO inhibits the activity of purified ODC. NO, in the form of S-nitrosocysteine (CysNO), S-nitrosoglutathione (GSNO), or 1, 1-diethyl-2-hydroxy-2-nitroso-hydrazine (DEA/NO), inhibited enzyme activity in a concentration-dependent manner. CysNO (1 microM) inhibited ODC activity by approximately 90% and 3 microM GSNO by more than 70%. DEA/NO was less potent, inhibiting enzyme activity by 70% at a concentration of 30 microM. Inhibition of enzyme activity by CysNO, GSNO, or DEA/NO was reversible by addition of dithiothreitol or glutathione. Cuprous ion (Cu (I)) also reversed the inhibitory effect of these NO donor agents. The data presented here support the hypothesis that NO inhibits ODC activity via S-nitrosylation of a critical cysteine residue(s) on ODC. CI - Copyright 1999 Academic Press. FAU - Bauer, P M AU - Bauer PM AD - Department of Molecular and Medical Pharmacology, University of California-Los Angeles School of Medicine, Los Angeles, California, 90095-1735, USA. FAU - Fukuto, J M AU - Fukuto JM FAU - Buga, G M AU - Buga GM FAU - Pegg, A E AU - Pegg AE FAU - Ignarro, L J AU - Ignarro LJ LA - eng GR - HL35014/HL/NHLBI NIH HHS/United States GR - HL40922/HL/NHLBI NIH HHS/United States GR - HL58433/HL/NHLBI NIH HHS/United States GR - etc. PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - Biochem Biophys Res Commun JT - Biochemical and biophysical research communications JID - 0372516 RN - 0 (Nitroso Compounds) RN - 0 (Ornithine Decarboxylase Inhibitors) RN - 0 (Sulfhydryl Compounds) RN - 31C4KY9ESH (Nitric Oxide) RN - 789U1901C5 (Copper) RN - EC 4.1.1.17 (Ornithine Decarboxylase) RN - K848JZ4886 (Cysteine) SB - IM MH - Catalytic Domain MH - Copper/pharmacology MH - Cysteine/*analogs & derivatives MH - Nitric Oxide/*pharmacology MH - Nitroso Compounds/*metabolism MH - Ornithine Decarboxylase/drug effects MH - *Ornithine Decarboxylase Inhibitors MH - Oxidation-Reduction MH - Sulfhydryl Compounds EDAT- 1999/08/27 00:00 MHDA- 1999/08/27 00:01 CRDT- 1999/08/27 00:00 PHST- 1999/08/27 00:00 [pubmed] PHST- 1999/08/27 00:01 [medline] PHST- 1999/08/27 00:00 [entrez] AID - 10.1006/bbrc.1999.1210 [doi] AID - S0006-291X(99)91210-X [pii] PST - ppublish SO - Biochem Biophys Res Commun. 1999 Aug 27;262(2):355-8. doi: 10.1006/bbrc.1999.1210.